Hypertensive retinopathy occurs when high blood pressure damages the delicate blood vessels in the retina, the light-sensitive tissue at the back of the eye. Prolonged hypertension causes these vessels (arterioles) to narrow, thicken, and become less flexible. This reduces blood flow to the retina, leading to symptoms such as blurred vision, headaches, and, in severe cases, vision impairment or even blindness.
The condition is classified into different stages based on the extent of damage, ranging from mild narrowing of arterioles (grade 1) to more severe signs like hemorrhages, exudates, and swelling of the optic nerve head (grades 2-4). Timely detection through regular eye exams is crucial for early intervention. Treatment involves managing blood pressure effectively through lifestyle changes and medications prescribed by a healthcare provider specializing in hypertension and its ocular complications. This approach aims to prevent progression and preserve vision integrity.
Background: Hypertension may lead to target organ damages associated with both microvascular and macrovascular complications. Retinal photography is a simple non-invasive tool that may detect retinal…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Hypertensive Retinopathy work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Hypertensive Retinopathy research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Hypertensive Retinopathy track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Hypertensive Retinopathy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Hypertensive Retinopathy are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Hypertensive Retinopathy track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
